# A Research Study Examining the Use of Olanzapine for the Prevention of Migraine

> **NCT00203307** · NA · TERMINATED · sponsor: **Thomas Jefferson University** · enrollment: 3 (actual)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** Olanzapine during first intervention period and placebo during second intervention period
- **DRUG:** Placebo during first intervention period, then olanzapine during second intervention period

## Key facts

- **NCT ID:** NCT00203307
- **Lead sponsor:** Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-05
- **Primary completion:** 2006-03
- **Final completion:** 2006-06
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Study terminated by sponsor
- **Last updated:** 2011-08-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00203307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00203307, "A Research Study Examining the Use of Olanzapine for the Prevention of Migraine". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00203307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*